Stocks On the Move: Alaska Air Group, Inc., Egalet Corp, and Signal Genetics Inc

ALK, EGLT, and SGNL are among the stocks on the move today

Jan 10, 2017 at 2:25 PM
facebook twitter linkedin


U.S. stocks are shaking off a sluggish start, with tech leading the way higher. Among specific equities in focus today are travel stock Alaska Air Group, Inc. (NYSE:ALK), drugmaker Egalet Corp (NASDAQ:EGLT), and diagnostics specialist Signal Genetics Inc (NASDAQ:SGNL). Here's a quick look at what's moving ALK, EGLT, and SGNL.

  • ALK has soared 5% to trade at $91.88, and earlier hit a record high of $92.49, amid a number of positive catalysts. First, the airline raised its full-year 2017 and 2018 earnings estimates and reported a 5.6% increase in December traffic. Second, BofA-Merrill Lynch upped its rating to "buy" from "neutral," and boosted its price target to $110 from $97, citing the company's expanded network after acquiring Virgin America. Third, T. Rowe Price Group Inc (NASDAQ:TROW) reported a 10.1% passive stake in Alaska Air Group, Inc. With nearly 8% of the stock's float sold short, it's safe to assume a number of ALK short sellers are feeling rattled by today's bullish gap.
  • A day after jumping on the Food and Drug Administration's (FDA) approval of its opioid painkiller Arymo, EGLT's shares are plunging after the drug's abuse-deterrent label disappointed. At last check, the stock has surrendered over 23% of its value at $6.44, on track for its lowest close since early November. While Egalet Corp is short-sale restricted at present, already one-third of the stock's float is dedicated to these bearish bets.
  • SGNL has rocketed to an 184% gain at $13.60, and is fresh off an annual peak of $15.19. Since this morning, the stock has been halted twice for volatility, just a day after Signal Genetics Inc set a special meeting to vote on a proposed merger with Miragen Therapeutics. From the looks of it, a number of bears dodged a huge bullet. Specifically, short interest plunged almost 71% over the last two reporting periods, leaving only 1.3% of SGNL's float sold short.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners